Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population

被引:27
作者
Bacsi, Krisztian [1 ]
Hitre, Erika [2 ]
Kosa, Janos P. [1 ]
Horvath, Henrik [1 ]
Lazary, Aron [1 ]
Lakatos, Peter L. [1 ]
Balla, Bernadett [1 ]
Budai, Barna [2 ]
Lakatos, Peter [1 ]
Speer, Gabor [1 ]
机构
[1] Semmelweis Univ, Dept Med 1, H-1083 Budapest, Hungary
[2] Natl Inst Oncol, H-1122 Budapest, Hungary
关键词
D O I
10.1186/1471-2407-8-317
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: Epidemiological studies suggested the chemopreventive role of higher calcium intake in colorectal carcinogenesis. We examined genetic polymorphisms that might influence calcium metabolism: lactase (LCT) gene 13910 C/T polymorphism causing lactose intolerance and calcium-sensing receptor (CaSR) gene A986S polymorphism as a responsible factor for the altered cellular calcium sensation. Methods: 538 Hungarian subjects were studied: 278 patients with colorectal cancer and 260 healthy controls. Median follow-up was 17 months. After genotyping, the relationship between LCT 13910 C/T and CaSR A986S polymorphisms as well as tumor incidence/progression was investigated. Results: in patient with colorectal cancer, a significantly higher LCT CC frequency was associated with increased distant disease recurrence (OR = 4.04; 95% CI = 1.71-9.58; p = 0.006). The disease free survival calculated from distant recurrence was reduced for those with LCT CC genotype (log rank test p = 0.008). In case of CaSR A986S polymorphism, the homozygous SS genotype was more frequent in patients than in controls (OR = 4.01; 95% CI = 1.33-12.07; p = 0.014). The number of LCT C and CaSR S risk alleles were correlated with tumor incidence (p = 0.035). The CCSS genotype combination was found only in patients with CRC (p = 0.033). Conclusion: LCT 13910 C/T and CaSR A986S polymorphisms may have an impact on the progression and/or incidence of CRC.
引用
收藏
页数:8
相关论文
共 33 条
[1]
Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein [J].
Awata, H ;
Huang, CF ;
Handlogten, ME ;
Miller, RT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :34871-34879
[2]
Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma [J].
Bhagavathula, N ;
Kelley, EA ;
Reddy, M ;
Nerusu, KC ;
Leonard, C ;
Fay, K ;
Chakrabarty, S ;
Varani, J .
BRITISH JOURNAL OF CANCER, 2005, 93 (12) :1364-1371
[4]
The extracellular calcium-sensing receptor: Its role in health and disease [J].
Brown, EM ;
Pollak, M ;
Hebert, SC .
ANNUAL REVIEW OF MEDICINE, 1998, 49 :15-29
[5]
Introducing genetic testing for adult-type hypolactasia [J].
Büning, C ;
Genschel, J ;
Jurga, J ;
Fiedler, T ;
Voderholzer, W ;
Fiedler, EM ;
Worm, M ;
Weltrich, R ;
Lochs, H ;
Schmidt, H ;
Ockenga, J .
DIGESTION, 2005, 71 (04) :245-250
[6]
DIRECT DEMONSTRATION OF INCREASED EXPRESSION OF THOMSEN-FRIEDENREICH (TF) ANTIGEN IN COLONIC ADENOCARCINOMA AND ULCERATIVE-COLITIS MUCIN AND ITS CONCEALMENT IN NORMAL MUCIN [J].
CAMPBELL, BJ ;
FINNIE, IA ;
HOUNSELL, EF ;
RHODES, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :571-576
[7]
Capurso G., 2006, DIGEST LIVER DIS, V38, P277
[8]
Lactose intolerance and sell-reported milk intolerance: Relationship with lactose maldigestion and nutrient intake [J].
Carroccio, A ;
Montalto, G ;
Cavera, G ;
Notarbatolo, A .
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1998, 17 (06) :631-636
[9]
Chakrabarty S, 2005, CANCER RES, V65, P493
[10]
Chakrabarty S, 2003, CANCER RES, V63, P67